Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective-Reference-Cited by-同舟云学术

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective

Published:2022-05-17 Issue:2 Volume:112 Page:344-352
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

de Jong Amos J.¹^ORCID,van Rijssel Tessa I.²,Zuidgeest Mira G. P.²,van Thiel Ghislaine J. M. W.²,Askin Scott³,Fons‐Martínez Jaime⁴,De Smedt Tim⁵,de Boer Anthonius¹⁶,Santa‐Ana‐Tellez Yared¹,Gardarsdottir Helga¹⁷⁸,

Affiliation:

1. Division of Pharmacoepidemiology and Clinical Pharmacology Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht The Netherlands

2. Julius Center for Health Sciences and Primary Care University Medical Center Utrecht Utrecht The Netherlands

3. Regulatory Affairs Innovation Novartis Pharma AG Basel Switzerland

4. The Foundation for the Promotion of Health and Biomedical Research of Valencia Region Valencia Spain

5. Global Regulatory Affairs UCB Pharma Brussels Belgium

6. Dutch Medicines Evaluation Board Utrecht The Netherlands

7. Department of Clinical Pharmacy Division Laboratory and Pharmacy University Medical Center Utrecht Utrecht The Netherlands

8. Faculty of Pharmaceutical Sciences University of Iceland Reykjavik Iceland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link